Ralph C. Schimmer
About
In The Last Decade
Ralph C. Schimmer
49 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 116
- Orthopedics and Sports Medicine 1.7k
- Oncology 1.5k
- Molecular Biology 770
- Surgery 570
- Pulmonary and Respiratory Medicine 510
Countries citing papers authored by Ralph C. Schimmer
This map shows the geographic impact of Ralph C. Schimmer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph C. Schimmer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph C. Schimmer more than expected).
Fields of papers citing papers by Ralph C. Schimmer
This network shows the impact of papers produced by Ralph C. Schimmer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph C. Schimmer. The network helps show where Ralph C. Schimmer may publish in the future.
Co-authorship network of co-authors of Ralph C. Schimmer
This figure shows the co-authorship network connecting the top 25 collaborators of Ralph C. Schimmer. A scholar is included among the top collaborators of Ralph C. Schimmer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph C. Schimmer. Ralph C. Schimmer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 7 | |
| 3 | 17 | |
| 4 | 9 | |
| 5 | 22 | |
| 6 | 193 | |
| 7 | 152 | |
| 8 | 25 | |
| 9 | Oral monthly ibandronate is well tolerated and efficacious in postmenopausal women: results from the monthly oral pilot study (MOPS) | 0 |
| 10 | Effects of Oral Ibandronate Administered Daily or Intermittently on Fracture Risk in Postmenopausal Osteoporosis breakdown → | 877 |
| 11 | 72 | |
| 12 | 142 | |
| 13 | 75 | |
| 14 | Oral monthly ibandronate decrease bone turnover in postmenopausal women with low bone mass: results from the monthly oral pilot study (MOPS) | 1 |
| 15 | 58 | |
| 16 | Efficacy and safety of oral weekly ibandronate in the treatment of postmenopausal osteoporosis (PMO) | 2 |
| 17 | 96 | |
| 18 | 66 | |
| 19 | 11 | |
| 20 | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.